Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2011-003030-14-IT
EUCTR2011-003030-14-IT
Active, not recruiting
Not Applicable

erve Growth Factor (NGF) eye drop administration as visual rescue treatment in visual loss-associated optic gliomas. - NGF in the optic gliomas

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sitesSeptember 3, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGliomaMedDRA version: 15.0Level: PTClassification code 10030953Term: Optic tract gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Eye Diseases [C11]

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glioma
Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Status
Active, not recruiting
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 3, 2012
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Eligibility Criteria

Inclusion Criteria

  • •children with established diagnosis of Optic Gliomas (OG)
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 22
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 2
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •children with OG associated with NF1 in RC treatment or have to finish treatment program till 12 mounths

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
erve Growth Factor eye drops as a novel treatment for patients with Retinitis Pigmentosa.Retinitis pigmentosa with cystoid macular edemaMedDRA version: 17.0Level: LLTClassification code 10054467Term: Macular edemaSystem Organ Class: 100000004853MedDRA version: 17.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2014-000385-22-ITOspedale San Raffaele di Milano
Completed
Phase 2
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular EdemaRetinitis PigmentosaCystoid Macular Edema
NCT02609165Ospedale San Raffaele45
Completed
Phase 2
A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry EyeDry Eye Syndrome
NCT03982368Dompé Farmaceutici S.p.A261
Active, not recruiting
Not Applicable
Verification of efficacy of root resection using CGF
JPRN-jRCTc020190025Saito Masahiro24
Completed
Not Applicable
Topical Platelet Derived Growth Factor (PDGF) Versus Placebo Therapy of Diabetic Foot Ulcers Off-Loaded with Windowed CastsDiabetic Foot UlcerSurgery - Other surgeryMetabolic and Endocrine - Diabetes
ACTRN12612001124820Heritage Provider Network, Inc46